Thermo Fisher Pharma 11 Miniature Twin-Screw Hot Melt Extruder

Overview

The Thermo Fisher Pharma 11 is a GMP-compliant, miniature co-rotating twin-screw hot melt extruder engineered for high-fidelity formulation development in pharmaceutical solid dosage form research. It operates on the fundamental principle of continuous melt processing—utilizing precise temperature control, screw speed modulation, and volumetric feed coordination to induce controlled thermal and mechanical energy input into thermoplastic polymer–API blends. Its core architecture reflects the geometric and kinematic design principles of Thermo Fisher’s industrial-scale twin-screw extrusion platforms, enabling direct linear scale-up from laboratory to pilot or commercial production. With a minimum throughput of 20 g/h, the Pharma 11 supports efficient use of scarce active pharmaceutical ingredients (APIs) and high-value excipients during early-stage formulation screening, polymorph stabilization studies, amorphous solid dispersion (ASD) development, and solubility enhancement trials.

Key Features

• GMP-ready stainless-steel construction with electropolished surfaces (Ra ≤ 0.4 µm) compliant with ISO 13485 and FDA 21 CFR Part 11 requirements for electronic records and signatures.
• Modular barrel system with six independently controlled heating/cooling zones (range: ambient to 300 °C), each equipped with Pt100 RTD sensors and ±0.5 °C thermal stability.
• Co-rotating intermeshing twin-screw configuration (11 mm screw diameter, L/D = 25) featuring segmented screw elements (conveying, kneading, reverse, mixing) for customizable shear history and residence time distribution.
• Gravimetric twin-screw feeder with dual load cells (0.01–10 g/min range, repeatability ±0.5% RSD) synchronized to main drive via CAN bus for closed-loop mass flow control.
• Integrated torque monitoring (0–100% full scale), melt pressure transducer (0–100 bar), and real-time melt temperature profiling at multiple axial positions.
• Touchscreen HMI with embedded recipe management, audit trail logging, and user-level access control (admin/operator/technician tiers).

Sample Compatibility & Compliance

The Pharma 11 accommodates a broad spectrum of thermolabile and shear-sensitive formulations—including polyvinylpyrrolidone (PVP), hydroxypropyl methylcellulose acetate succinate (HPMCAS), Eudragit® grades, and low-Tg polymers—without degradation under optimized process windows. Its design conforms to ICH Q5A (viral safety), Q5C (stability), and Q8(R3) (pharmaceutical development) guidance frameworks. All wetted parts meet USP Class VI biocompatibility standards. The system supports qualification protocols per ASTM F2965 (standard guide for validation of pharmaceutical extrusion processes) and is routinely deployed in GLP-compliant laboratories for pre-IND formulation characterization. Documentation packages include IQ/OQ/PQ templates aligned with Annex 15 and EU GMP Annex 15 requirements.

Software & Data Management

Control and data acquisition are managed through Thermo Fisher’s proprietary Extrusion Control Suite (ECS v3.2), a validated Windows-based application supporting 21 CFR Part 11 compliance. ECS provides real-time visualization of 32+ process variables—including screw speed, barrel zone temperatures, feed rate, torque, pressure, and melt temperature—with configurable alarm thresholds and automatic event-triggered data capture. All raw data are stored in encrypted SQLite databases with immutable timestamps and operator ID stamps. Audit trails record all parameter changes, method uploads, and user logins with retention ≥30 years. Export formats include CSV, PDF reports (with digital signature), and XML for integration into LIMS or MES environments.

Applications

• Amorphous solid dispersion (ASD) development for BCS Class II/IV compounds
• Hot-melt extrusion (HME) process mapping and design space definition per ICH Q5E
• Clinical trial material (CTM) manufacturing under cGMP conditions (up to Phase III)
• Excipient compatibility screening and thermal degradation kinetics assessment
• Residence time distribution (RTD) analysis using tracer studies
• Scale-up correlation studies linking lab-scale (Pharma 11), pilot-scale (Pharma 16), and production-scale (Pharma 24/36) extruders

FAQ

Is the Pharma 11 suitable for processing highly potent compounds (HPAPIs)?

Yes—the system supports optional containment integration (e.g., glovebox coupling, split-flange feed hoppers) and can be operated under negative pressure with HEPA filtration for OEL ≤10 ng/m³.
Can process data from the Pharma 11 be used directly for regulatory submissions?

Yes—when operated under validated conditions with full ECS audit trail enabled, data meet ALCOA+ criteria and are accepted by EMA, FDA, and PMDA for CMC sections of IND/NDA filings.
What is the typical lead time for installation and qualification support?

Standard delivery includes factory acceptance testing (FAT); on-site IQ/OQ support is available within 4–6 weeks post-shipment, contingent on facility readiness and local utility compliance.
Does Thermo Fisher provide scale-up modeling tools alongside the Pharma 11?

Yes—the Extrusion Scale-Up Toolkit (ESUT) software package enables dimensional and dynamic similarity analysis based on dimensionless numbers (Re, Fr, We) and empirical power-law correlations derived from Pharma-series extruder databases.